Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres

被引:209
作者
Kuter, David J.
Bain, Barbara
Mufti, Ghulam
Bagg, Adam
Hasserjian, Robert P.
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
[2] St Marys Hosp, London, England
[3] Kings Coll Hosp London, London, England
[4] Penn State Univ Hosp, Philadelphia, PA USA
关键词
reticulin; collagen; myelofibrosis; myeloproliferative disease; thrombopoietin; GROWTH-FACTOR-BETA; HEMATOPOIETIC-CELL TRANSPLANTATION; CHRONIC MYELOGENOUS LEUKEMIA; INTERNATIONAL-WORKING-GROUP; COLONY-STIMULATING FACTOR; MYELOID METAPLASIA; IDIOPATHIC MYELOFIBROSIS; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; SILVER IMPREGNATION;
D O I
10.1111/j.1365-2141.2007.06807.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In bone marrow biopsies, stromal structural fibres are detected by reticulin and trichrome stains, routine stains performed on bone marrow biopsy specimens in diagnostic laboratories. Increased reticulin staining (reticulin fibrosis) is associated with many benign and malignant conditions while increased trichrome staining (collagen fibrosis) is particularly prominent in late stages of severe myeloproliferative diseases or following tumour metastasis to the bone marrow. Recent evidence has shown that the amount of bone marrow reticulin staining often exhibits no correlation to disease severity, while the presence of type 1 collagen, as detected by trichrome staining, is often associated with more severe disease and a poorer prognosis. It was originally thought that increases in bone marrow stromal fibres themselves contributed to the haematopoietic abnormalities seen in certain diseases, but recent studies suggest that these increases are a result of underlying cellular abnormalities rather than a cause. A growing body of evidence suggests that increased deposition of bone marrow stromal fibres is mediated by transforming growth factor-beta and other factors elaborated by megakaryocytes, but it is likely that other cells, cytokines and growth factors are also involved. This suggests new avenues for investigation into the pathogenesis of various disorders associated with increased bone marrow stromal fibres.
引用
收藏
页码:351 / 362
页数:12
相关论文
共 98 条
[1]  
ANTIN JH, 1990, EXP HEMATOL, V18, P266
[2]  
Bain BJ., 2001, BONE MARROW PATHOLOG, V3rd
[3]  
Bancroft JD., 2002, Theory and practice of histological techniques, V5
[4]   Myelofibrosis with myeloid metaplasia: Diagnostic definition and prognostic classification for clinical studies and treatment guidelines [J].
Barosi, G .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2954-2970
[5]   Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET) [J].
Barosi, G ;
Bordessoule, D ;
Briere, J ;
Cervantes, F ;
Demory, JL ;
Dupriez, B ;
Gisslinger, H ;
Griesshammer, M ;
Hasselbalch, H ;
Kusec, R ;
Le Bousse-Kerdiles, MC ;
Liberato, NL ;
Marchetti, M ;
Reilly, JT ;
Thiele, J .
BLOOD, 2005, 106 (08) :2849-2853
[6]  
Bass RD, 2001, AM J CLIN PATHOL, V116, P211
[7]  
BAUERMEISTER DE, 1971, AM J CLIN PATHOL, V56, P24
[8]  
BECKMAN EN, 1990, ARCH PATHOL LAB MED, V114, P1241
[9]   Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis [J].
Beham-Schmid, C ;
Apfelbeck, U ;
Sill, H ;
Tsybrovsky, O ;
Höfler, G ;
Haas, OA ;
Linkesch, W .
BLOOD, 2002, 99 (01) :381-383
[10]   COLLAGEN HETEROGENEITY IN NORMAL HUMAN-BONE MARROW [J].
BENTLEY, SA ;
ALABASTER, O ;
FOIDART, JM .
BRITISH JOURNAL OF HAEMATOLOGY, 1981, 48 (02) :287-291